A potential role for Galectin-3 inhibitors in the treatment of COVID-19

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), the causative agent of coronavirus disease 2019 (COVID-19), has been declared a global pandemic by the World Health Organization. With no standard of care for the treatment of COVID-19, there is an urgent need to identify t...

Descripción completa

Detalles Bibliográficos
Autores principales: Caniglia, John L., Guda, Maheedhara R., Asuthkar, Swapna, Tsung, Andrew J., Velpula, Kiran K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2020
Materias:
Cell Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301894/
https://www.ncbi.nlm.nih.gov/pubmed/32587806
http://dx.doi.org/10.7717/peerj.9392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301894/
https://www.ncbi.nlm.nih.gov/pubmed/32587806
http://dx.doi.org/10.7717/peerj.9392

Ejemplares similares